High prevalence of Wilms tumor 1 expression in multiple myeloma and plasmacytoma: A cohort of 142 Asian patients’ samples

Wilms tumor 1 (WT1) is a promising target antigen for cancer immunotherapy. However, WT1 protein expression and its clinical correlation in multiple myeloma (MM) patients are still limited. We, therefore, investigated WT1 expression in 142 bone marrow and plasmacytoma samples of MM patients at diffe...

Descripción completa

Detalles Bibliográficos
Autores principales: Phikulsod, Ployploen, Sukpanichnant, Sanya, Kunacheewa, Chutima, Chieochansin, Thaweesak, Junking, Mutita, Yenchitsomanus, Pa-Thai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pathology and Oncology Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902379/
https://www.ncbi.nlm.nih.gov/pubmed/36760714
http://dx.doi.org/10.3389/pore.2023.1610844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902379/
https://www.ncbi.nlm.nih.gov/pubmed/36760714
http://dx.doi.org/10.3389/pore.2023.1610844

Ejemplares similares